111 Inc (YI)
1.06
+0.04
(+3.92%)
USD |
NASDAQ |
Apr 22, 16:00
1.055
0.00 (0.00%)
After-Hours: 20:00
111 Revenue (TTM): 2.126B for Sept. 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | 2.126B |
| June 30, 2023 | 2.108B |
| March 31, 2023 | 2.072B |
| December 31, 2022 | 2.001B |
| September 30, 2022 | 1.958B |
| June 30, 2022 | 1.986B |
| March 31, 2022 | 1.995B |
| December 31, 2021 | 1.925B |
| September 30, 2021 | 1.783B |
| June 30, 2021 | 1.608B |
| March 31, 2021 | 1.368B |
| Date | Value |
|---|---|
| December 31, 2020 | 1.194B |
| September 30, 2020 | 986.98M |
| June 30, 2020 | 804.01M |
| March 31, 2020 | 698.16M |
| December 31, 2019 | 569.58M |
| September 30, 2019 | 458.85M |
| June 30, 2019 | 373.70M |
| March 31, 2019 | 313.75M |
| December 31, 2018 | 268.54M |
| September 30, 2018 | 229.64M |
| June 30, 2018 | 193.78M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
373.70M
Minimum
Jun 2019
2.126B
Maximum
Sep 2023
1.445B
Average
1.696B
Median
Revenue (TTM) Benchmarks
| Concord Medical Services Holdings Ltd | 75.73M |
| Sinovac Biotech Ltd | 420.88M |
| CASI Pharmaceuticals Inc | 33.88M |
| Zai Lab Ltd | 266.72M |
| I-MAB | -35.63M |